Literature DB >> 14999561

Chasing genes in Alzheimer's and Parkinson's disease.

Aida M Bertoli-Avella1, Ben A Oostra, Peter Heutink.   

Abstract

Alzheimer's disease (AD), the most common type of dementia, and Parkinson's disease (PD), the most common movement disorder, are both neurodegenerative adult-onset diseases characterized by the progressive loss of specific neuronal populations and the accumulation of intraneuronal inclusions. The search for genetic and environmental factors that determine the fate of neurons during the ageing process has been a widespread approach in the battle against neurodegenerative disorders. Genetic studies of AD and PD initially focused on the search for genes involved in the aetiological mechanisms of monogenic forms of these diseases. They later expanded to study hundreds of patients, affected relative-pairs and population-based studies, sometimes performed on "special" isolated populations. A growing number of genes (and pathogenic mutations) is being identified that cause or increase susceptibility to AD and PD. This review discusses the way in which strategies of "gene hunting" have evolved during the last few years and the significance of finding genes such as the presenilins, alpha- synuclein, parkin and DJ- 1. In addition, we discuss possible links between these two neurodegenerative disorders. The clinical, pathological and genetic presentation of AD and PD suggests the involvement of a few overlapping interrelated pathways. Their imbricate features point to a spectrum of neurodegeneration (tauopathies, synucleinopathies, amyloidopathies) that need further intense investigation to find the missing links.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999561     DOI: 10.1007/s00439-004-1097-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  288 in total

1.  The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.

Authors:  Alexander Zimprich; Bertram Müller-Myhsok; Matthew Farrer; Petra Leitner; Manu Sharma; Mary Hulihan; Paul Lockhart; Audrey Strongosky; Jennifer Kachergus; Donald B Calne; Jon Stoessl; Ryan J Uitti; Ronald F Pfeiffer; Claudia Trenkwalder; Nikolaus Homann; Erwin Ott; Karoline Wenzel; Friedrich Asmus; John Hardy; Zbigniew Wszolek; Thomas Gasser
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

2.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

3.  Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I.

Authors:  U Finckh; A Alberici; M Antoniazzi; L Benussi; V Fedi; C Giannini; A Gal; R M Nitsch; G Binetti
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

4.  Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing.

Authors:  G Yu; M Nishimura; S Arawaka; D Levitan; L Zhang; A Tandon; Y Q Song; E Rogaeva; F Chen; T Kawarai; A Supala; L Levesque; H Yu; D S Yang; E Holmes; P Milman; Y Liang; D M Zhang; D H Xu; C Sato; E Rogaev; M Smith; C Janus; Y Zhang; R Aebersold; L S Farrer; S Sorbi; A Bruni; P Fraser; P St George-Hyslop
Journal:  Nature       Date:  2000-09-07       Impact factor: 49.962

5.  Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease.

Authors:  P Chan; X Jiang; L S Forno; D A Di Monte; C M Tanner; J W Langston
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

6.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins.

Authors:  M Gatz; N L Pedersen; S Berg; B Johansson; K Johansson; J A Mortimer; S F Posner; M Viitanen; B Winblad; A Ahlbom
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1997-03       Impact factor: 6.053

7.  Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age.

Authors:  R C Mohs; J C Breitner; J M Silverman; K L Davis
Journal:  Arch Gen Psychiatry       Date:  1987-05

8.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

Authors:  M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

9.  S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relationship.

Authors:  Alexis Elbaz; Clotilde Levecque; Jacqueline Clavel; Jean-Sébastien Vidal; Florence Richard; Jean-René Corrèze; Bernard Delemotte; Philippe Amouyel; Annick Alpérovitch; Marie-Christine Chartier-Harlin; Christophe Tzourio
Journal:  Mov Disord       Date:  2003-02       Impact factor: 10.338

10.  Lack of association of the two polymorphisms in alpha-2 macroglobulin with Alzheimer disease.

Authors:  S E Poduslo; B Shook; E Drigalenko; X Yin
Journal:  Am J Med Genet       Date:  2002-06-01
View more
  13 in total

1.  Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.

Authors:  Yufeng Yang; Stephan Gehrke; Yuzuru Imai; Zhinong Huang; Yingshi Ouyang; Ji-Wu Wang; Lichuan Yang; M Flint Beal; Hannes Vogel; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

Review 2.  Recent advances in using Drosophila to model neurodegenerative diseases.

Authors:  Bingwei Lu
Journal:  Apoptosis       Date:  2009-08       Impact factor: 4.677

3.  Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery.

Authors:  Yufeng Yang; Yingshi Ouyang; Lichuan Yang; M Flint Beal; Angus McQuibban; Hannes Vogel; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

4.  PARK2 and PARK7 Gene Polymorphisms as Risk Factors Associated with Serum Element Concentrations and Clinical Symptoms of Parkinson's Disease.

Authors:  Jaya Sanyal; Athira Anirudhan; Tapas Kumar Banerjee; Gautam Guha; Ram Murugesan; S S J Shiek Ahmed; Vadlamudi Raghavendra Rao
Journal:  Cell Mol Neurobiol       Date:  2019-09-11       Impact factor: 5.046

Review 5.  Molecular mechanisms of neurodegeneration in Alzheimer's disease.

Authors:  Leslie Crews; Eliezer Masliah
Journal:  Hum Mol Genet       Date:  2010-04-22       Impact factor: 6.150

6.  Understanding and treating neurodegeneration: insights from the flies.

Authors:  Bingwei Lu
Journal:  Age (Dordr)       Date:  2005-12-31

Review 7.  Drosophila models of neurodegenerative diseases.

Authors:  Bingwei Lu; Hannes Vogel
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

8.  The Association between Sporadic Alzheimer's Disease and the Human ABCA1 and APOE Gene Polymorphisms in Iranian Population.

Authors:  H R Khorram Khorshid; E Gozalpour; K Kamali; M Ohadi; M Karimloo; M H Shahhosseiny
Journal:  Iran Red Crescent Med J       Date:  2011-04-01       Impact factor: 0.611

Review 9.  APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.

Authors:  Leslie Crews; Edward Rockenstein; Eliezer Masliah
Journal:  Brain Struct Funct       Date:  2009-11-29       Impact factor: 3.270

10.  Association between Alzheimer's Disease and Apolipoprotein E Polymorphisms.

Authors:  E Gozalpour; K Kamali; K Mohammd; Hr Khorram Khorshid; M Ohadi; M Karimloo; A Mirabzadeh; A Fotouhi
Journal:  Iran J Public Health       Date:  2010-06-30       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.